Malnutrition, infection and arteriovenous fistula failure: Is there a link?

Journal of Vascular Access

Volumn 12, Issue 1, 2011, Pages 57-62

  Gagliardi, Gian Manlio ^a   Rossi, Stefania ^a   Condino, Francesca ^b   Mancuso, Domenico ^c   Greco, Francesca ^a   Tenuta, Robert ^a   Savino, Olga ^a   Bonofiglio, Renzo ^a   Domma, Filippo ^d   Latorre, Giovanni ^d  

^a Annunziata Hospital   (Italy)

^b INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^c San Giacomo Hospital   (Italy)

^d UNIVERSITY OF CALABRIA   (Italy)

Author keywords

Arteriovenous fistula failure; Hemodialysis; Infection; Stenosis; Thrombosis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; FIBRINOGEN; IMMUNOGLOBULIN G;

ADULT; ALBUMIN BLOOD LEVEL; ARTERIOVENOUS FISTULA; ARTICLE; ATHEROGENESIS; BLOOD FLOWMETRY; CHLAMYDIAL PNEUMONIA; CHOLESTEROL BLOOD LEVEL; CYTOMEGALOVIRUS; DIABETES MELLITUS; DISEASE PREDISPOSITION; FEMALE; FIBRINOGEN BLOOD LEVEL; HELICOBACTER INFECTION; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; NUTRITIONAL ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEIN INTAKE; RISK FACTOR; SMOKING;

EID: 79953754916     PISSN: 11297298     EISSN: None     Source Type: Journal    
DOI: 10.5301/JVA.2010.5831     Document Type: Article

References (22)

1. Chi-Jen-Chang, Yu-Saienco, Lung-An Hsu. Thrombosed arteriovenous fistula for hemodialysis access is characterized by a marked inflammatory activity. Kidney Int 2005; 68: 1312-9.
2. Hofstra L, Tordoir JHM, Kitslaar PJ, et al. Enhanced cell proliferation in intact stenotic lesions derived from human arteriovenous fistulae and peripheral bypass grafts: does it correlate with flow parameters. Circulation 1996; 94: 1283-90.
3. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115-26.
4. Kuo CC, Shor A, Campbell LA, et al. Demonstration of Chlamydia pneumoniae in atherosclerosis lesions of coronary arteries. J Infect Dis 1993; 167: 841-9.
5. Jackson LA, Campbell LA, Kuo CC, et al. Isolation of Chlamydia pneumoniae from a carotid endoarterectomy specimen. J Infect Dis 1997; 176: 292-5.
6. Juvonen J, Juvonen T, Laurila A, et al. Demonstration of Chlamydia pneumonite in the walls of abdominal aortic aneurysm. J Vasc Surg 1997; 25: 499-505.
7. Ramirez JA on behalf of Chlamydia pneumoniae/Atherosclerosis Study Group. Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. Ann Intern Med 1996; 125: 979-82.
8. Mendall MA, Goggin PM, Molineaux N, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J 1994; 71: 437-39.
9. Patel P, Mendall MA, Carrington D, et al. Association of Helicobacter pilori and Chlamydia pneumoniae infection with coronary heart disease and cardiovascular risk factors. BMJ 1995; 311: 711-4.
10. Markus HS, Mendall MA. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry 1998; 64: 104-7.
11. Elizalde JI, Gonaz J, Panes J, et al. Platelet activation in mice and human helicobacter pylori infection. J Clin Invest 1997; 100: 996-1005.
12. Zhou YF, Leon MB, Waclawiw MA, et al. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. N Engl J Med 1996; 335: 624-30.
13. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 256: 391-4.
14. Muhlestein JB, Horne BD, Carlquist JF, et al. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease. Circulation 2000; 102: 1917-23.
15. Grandaliano G, Teutonico A, Allegretti A, et al. The role of hyperparathyroidism, erythropoietin therapy, and CMV infection in the failure of arteriovenous fistula in hemodialysis. Kidney Int 2003; 64: 715-9.
16. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: recommendation from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 2001; 33: 492-503.
17. Roy-Chaudhury P. Endothelial progenitor cells, neointimal hyperplasia, and vascular access dysfunction: novel therapies for a recalcitrant clinical problem. Circulation 2005; 112: 3-5.
18. Kalayoglu MU, Hoerweman B, LaVerda D, et al. Cellular oxidation of low-density protein by Chlamidia pneumoniae. J Infect Dis 1999; 180: 780-90.
19. Zydlewski AW, Stothard DR, Van Der Pol BS, et al. Is there a role for Chlamydia pneumoniae in hemodialysis vascular access thrombosis? Am J Kidney Dis 2000; 36: 1122-5.
20. National Kidney Foundation K/DOQI Clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 2003; 41 (suppl): S22-59.
21. Liu Y, Coresh J, Eustace JA. Association between cholesterol level and mortality in dialysis patients. JAMA 2004; 291: 451-9.
22. Stenvinkel P, Heimburger O, Lindholm B, Kaisen GA, Bergstrom J. Are there two types of malnutrition in chronic renal failure? Evidence for relationship between malnutrition, inflammation and atherosclerosis (MIA syndrome). Nephrol Dial Transplant 2000; 15: 953-60.